Patient-Reported Outcomes in Cancer Clinical Trials – European Cancer Organisation

EMA advisor discusses real-world data and single-arm trials in oncology drug approvals

Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in th

European Multiple Myeloma Patients Face Unequal Access to Curative Treatments

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

Natera's Signatera Wins EU Certification for Cancer Recurrence Monitoring

Certification allows Natera to keep offering the cancer-recurrence test across the EU as the bloc phases out its previous device framework.

Modelling Study Projects Rapid Growth in Radioligand Therapy Patient Populations Across EU and UK Healthcare Systems

The expected uptake of RLTs in EU healthcare systems over the coming decade may overwhelm available treatment capacity, even in countries wi

Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on

<![CDATA[Epcoritamab/R2 Earns European Approval for R/R Follicular Lymphoma]]>